Ian F. Smith, EVP, CFO & COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,842 shares at $87.66 ($337K) on 2017-02-13, disclosed to the SEC on 2017-02-15.
Scheduled sale ($337k) by EVP, CFO & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |